Intrabreath analysis of carbon monoxide uptake during exercise in patients at risk for lung injury.

[1]  C. Hsia,et al.  Nitric oxide diffusing capacity and alveolar microvascular recruitment in sarcoidosis. , 2004, American journal of respiratory and critical care medicine.

[2]  N. MacIntyre,et al.  Intrabreath diffusing capacity of the lung in healthy individuals at rest and during exercise. , 2002, Chest.

[3]  D. Dabdub,et al.  Effect of alveolar volume and sequential filling on the diffusing capacity of the lungs: II. Experiment. , 2000, Respiration physiology.

[4]  D. Berry,et al.  Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Y. C. Huang,et al.  Normal values for single exhalation diffusing capacity and pulmonary capillary blood flow in sitting, supine positions, and during mild exercise. , 1994, Chest.

[6]  C. Piantadosi,et al.  Pulmonary drug toxicity in patients with primary breast cancer treated with high-dose combination chemotherapy and autologous bone marrow transplantation. , 1993, The American review of respiratory disease.

[7]  D. Lockwood,et al.  DLCO/Q and diffusion limitation at rest and on exercise in patients with interstitial fibrosis. , 1991, Respiration physiology.

[8]  D. Johns,et al.  Single breath carbon monoxide diffusing capacity (transfer factor) , 1988, The American review of respiratory disease.

[9]  J. Cotes,et al.  Lung transfer factor and KCO at cardiac frequency 100 beats/min as a guide to impaired function of lung parenchyma. , 1984, Thorax.

[10]  W. Henry,et al.  Non-invasive measurement of cardiac output by a single breath constant expiratory technique. , 1984, Thorax.

[11]  J. Crapo,et al.  Comparison of total lung diffusion capacity and the membrane component of diffusion capacity as determined by physiologic and morphometric techniques. , 1983, Respiration physiology.

[12]  N. MacIntyre,et al.  Nonlinear increases in diffusing capacity during exercise by seated and supine subjects. , 1981, Journal of applied physiology: respiratory, environmental and exercise physiology.

[13]  D. Kleinbaum,et al.  Applied Regression Analysis and Other Multivariate Methods , 1978 .

[14]  J. Nadel,et al.  Pulmonary diffusing capacity measured at multiple intervals during a single exhalation in man. , 1977, Journal of applied physiology: respiratory, environmental and exercise physiology.

[15]  M. Sackner,et al.  Vertical distributions of pulmonary diffusing capacity and capillary blood flow in man. , 1973, The Journal of clinical investigation.

[16]  R. Forster,et al.  Measurement of uneven distribution of pulmonary blood flow to CO diffusing capacity. , 1971, Journal of applied physiology.

[17]  R. Hyde,et al.  Determination of distribution of diffusing capacity in relation to blood flow in the human lung. , 1967, The Journal of clinical investigation.

[18]  C T DOLLERY,et al.  DISTRIBUTION OF BLOOD FLOW IN ISOLATED LUNG; RELATION TO VASCULAR AND ALVEOLAR PRESSURES. , 1964, Journal of applied physiology.

[19]  C. Dollery,et al.  Regional variations in uptake of radioactive CO in the normal lung. , 1960, Journal of applied physiology.

[20]  D. Berry,et al.  A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies , 1996, Cancer Chemotherapy and Pharmacology.

[21]  J. Hankinson,et al.  American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update. , 1995, American journal of respiratory and critical care medicine.

[22]  D. Hurd,et al.  Randomized, comparative study of high-dose (with autologous bone marrow support) versus low-dose cyclophosphamide, cisplatin, and carmustine as consolidation to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for patients with operable stage II or III breast cancer involving 10 or more axil , 1995, Journal of the National Cancer Institute. Monographs.

[23]  T. Martonen,et al.  Theoretical basis of single breath gas absorption tests , 1982, Journal of mathematical biology.

[24]  A. Harf,et al.  Regional distribution of VA/Q in man at rest and with exercise measured with krypton-81m. , 1978, Journal of applied physiology: respiratory, environmental and exercise physiology.